Nanomedicine News RSS Feed - Nanomedicine

NanoViricides Presents FluCide Data at 3rd Annual Influenza Research and Development Conference

NanoViricides Presents FluCide Data at 3rd Annual Influenza Research and Development Conference

NanoViricides, Inc. reports that its President, Dr. Anil Diwan, was invited to present the FluCide™ data at the 3rd Annual Influenza Research and Development Conference on Friday, July 11, at 0850 am. [More]
Thomson Reuters Honors UNM Cancer Center Scientist on 2014 List of ‘Highly-Cited Researchers’

Thomson Reuters Honors UNM Cancer Center Scientist on 2014 List of ‘Highly-Cited Researchers’

Of the 7 billion people in the world, Thomson Reuters, chose only 3,200 for its recent list of “The World’s Most Influential Scientific Minds.” Vittorio Cristini, PhD, of the University of New Mexico Cancer Center, places among them. Dr. Cristini says, “I never expected this. It is truly amazing. I’m thrilled.” [More]
Market Opportunities Report on Poorly Soluble and Poorly Permeable Drugs

Market Opportunities Report on Poorly Soluble and Poorly Permeable Drugs

Poor bioavailability is a major reason for compounds to fail in preclinical development. Technology Catalysts International (TCI), a leading global pharmaceutical consulting firm, has compiled and analyzed technical and market information pertaining to the delivery of poorly water soluble or poorly permeable pharmaceutical compounds. [More]
Novel Nanotech Microchip for Diagnosis of Type-1 Diabetes

Novel Nanotech Microchip for Diagnosis of Type-1 Diabetes

An inexpensive, portable, microchip-based test for diagnosing type-1 diabetes could improve patient care worldwide and help researchers better understand the disease, according to the device's inventors at the Stanford University School of Medicine. [More]
Photoacoustic Tomography Illuminates ‘Nanojuice’ in the Intestine

Photoacoustic Tomography Illuminates ‘Nanojuice’ in the Intestine

Located deep in the human gut, the small intestine is not easy to examine. X-rays, MRIs and ultrasound images provide snapshots, but each suffers limitations. [More]
New Nanoengineering Undergraduate Certificate Program at Wayne State

New Nanoengineering Undergraduate Certificate Program at Wayne State

Beginning in winter 2015, Wayne State University’s College of Engineering will offer a nanoengineering undergraduate certificate program that will provide students with in-depth training in the emerging area of nanotechnology. The program will offer new lecture, laboratory and seminar courses that cross traditional departmental and disciplinary boundaries. [More]
DNA Nanopyramids Can Flag and Kill Bacteria

DNA Nanopyramids Can Flag and Kill Bacteria

Bacterial infections usually announce themselves with pain and fever but often can be defeated with antibiotics — and then there are those that are sneaky and hard to beat. Now, scientists have built a new weapon against such pathogens in the form of tiny DNA pyramids. [More]
Interactive Webinar on Clinical and Economic Case for Rapid Sepsis Diagnostics

Interactive Webinar on Clinical and Economic Case for Rapid Sepsis Diagnostics

Nanosphere, Inc., a company enhancing medicine through targeted molecular diagnostics, today announced that it will host an interactive webinar entitled: “Each Hour Counts: The Clinical and Economic Case for Rapid Sepsis Diagnostics.” The complimentary webinar will be held on Thursday, July 17, 2014 at 1:00 p.m. EDT. [More]
Platin-M Entrapped in a Nanoparticle Interferes with Mitochondria's DNA and Triggers Cell Death

Platin-M Entrapped in a Nanoparticle Interferes with Mitochondria's DNA and Triggers Cell Death

University of Georgia researchers have developed a new formulation of cisplatin, a common chemotherapy drug, that significantly increases the drug's ability to target and destroy cancerous cells. [More]
Researchers Employ DNA Origami to Test Theories About Cell Signalling

Researchers Employ DNA Origami to Test Theories About Cell Signalling

Researchers at Karolinska Institutet in Sweden have headed a study that has provided new knowledge about the EphA2 receptor, which is significant in several forms of cancer. This is important knowledge in itself – but just as important is how this study, which is published in the highly respected journal Nature Methods today, was conducted. [More]